You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

20-162

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
Mar 23, 2022

Endometriosis Trial in Worldwide (75 mg linzagolix tablet, 200 mg linzagolix tablet, Placebo tablet to match 75 mg linzagolix

Active, not recruiting
  • Endometriosis
  • 75 mg linzagolix tablet
  • +5 more
  • Dothan, Alabama
  • +46 more
Jan 12, 2023

Amyotrophic Lateral Sclerosis Trial (AMT-162)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • (no location specified)
Oct 20, 2023

Respiratory Syncytial Virus Prevention Trial in Japan (Ad26/protein preF RSV Vaccine, Placebo)

Recruiting
  • Respiratory Syncytial Virus Prevention
  • Ad26/protein preF RSV Vaccine
  • Placebo
  • Akashi-shi, Japan
  • +29 more
Aug 2, 2022

Dermatomyositis Trial in Worldwide (human immunoglobulin G, Placebo)

Recruiting
  • Dermatomyositis
  • human immunoglobulin G
  • Placebo
  • Glendale, Arizona
  • +75 more
Nov 1, 2022

Liver Cirrhoses Trial in Hvidovre (Placebo oral tablet, Atorvastatin 10mg)

Terminated
  • Liver Cirrhoses
  • Placebo oral tablet
  • Atorvastatin 10mg
  • Hvidovre, Danmark, Denmark
    Gastro Unit, medical Division, University Hospital Hvidovre
Jan 11, 2023

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (Biological/Vaccine: BNT162b2 10mcg, BNT162b2 20mcg, BNT162b2 30mcg)

Active, not recruiting
  • SARS-CoV-2 Infection, COVID-19
  • Biological/Vaccine: BNT162b2 10mcg
  • +4 more
  • Birmingham, Alabama
  • +134 more
Jan 23, 2023

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Healthy Volunteers Trial in Baltimore, Springfield (ASA, non-enteric-coated chewable aspirin)

Recruiting
  • Healthy Volunteers
  • ASA
  • non-enteric-coated chewable aspirin
  • Baltimore, Maryland
  • +1 more
Nov 21, 2022

Painful Diabetic Neuropathy Trial in Worldwide (trazodone/gabapentin 2.5/25 mg, trazodone/gabapentin 5/50 mg,

Completed
  • Painful Diabetic Neuropathy
  • trazodone/gabapentin 2.5/25 mg
  • +4 more
  • Litomyšl, 570 01, Czechia
  • +29 more
May 26, 2021

Obstructive Pulmonary Function, Restrictive Pulmonary Function Trial in Winter Park, Baltimore, Berlin (single dose (100 mg) of

Not yet recruiting
  • Obstructive Pulmonary Function
  • Restrictive Pulmonary Function
  • single dose (100 mg) of ASA
  • single dose (162 mg) of non-enteric-coated chewable aspirin tablets
  • Winter Park, Florida
  • +2 more
Nov 21, 2022

Preeclampsia Trial in Peoria (Aspirin 162 mg)

Recruiting
  • Preeclampsia
  • Aspirin 162 mg
  • Peoria, Illinois
    UnityPoint Clinic Family Medicine
Jan 22, 2022

Rheumatoid Arthritis Trial in China (Tocilizumab, MTX, Placebo Matched to MTX)

Completed
  • Rheumatoid Arthritis
  • Baotou, China
  • +19 more
Dec 5, 2022

Hypoxia Trial in Ankara (Normobaric Hypoxia Exposure, Normobaric Normoxia Exposure)

Completed
  • Hypoxia
  • Normobaric Hypoxia Exposure
  • Normobaric Normoxia Exposure
  • Ankara, Turkey
    Ankara University
Jul 22, 2023

Neuromyelitis Optica (NMO), NMO Spectrum Disorder (NMOSD) Trial in Worldwide (Satralizumab, Placebo, Baseline Treatment)

Completed
Has Results
  • Neuromyelitis Optica (NMO)
  • NMO Spectrum Disorder (NMOSD)
  • Birmingham, Alabama
  • +38 more
Jan 24, 2022

Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

Completed
Has Results
  • Tardive Dyskinesia
  • Tuscaloosa, Alabama
  • +81 more
Mar 31, 2022

Eosinophilic Gastritis, Eosinophilic Gastroenteritis Trial in Worldwide (Benralizumab, Placebo)

Recruiting
  • Eosinophilic Gastritis
  • Eosinophilic Gastroenteritis
  • Benralizumab
  • Placebo
  • Phoenix, Arizona
  • +85 more
Aug 4, 2022

Osteoarthritis Trial in Farmington (Ketorolac Tromethamine Injection, Methylprednisolone Acetate Injection, Hylan G-F 20)

Terminated
Has Results
  • Osteoarthritis
  • Ketorolac Tromethamine Injection
  • +2 more
  • Farmington, Connecticut
    UConn Health
Feb 5, 2020

Hepatocellular Carcinoma (HCC) Trial in Worldwide (Tislelizumab)

Completed
  • Hepatocellular Carcinoma (HCC)
  • Hefei, Anhui, China
  • +64 more
Jul 20, 2022

COVID-19 Trial in Worldwide (AT-527, Placebo)

Completed
  • COVID-19
  • Blagoevgrad, Bulgaria
  • +42 more
Nov 1, 2021

SARS-CoV-2 Infection, COVID-19 Trial in Sumida-ku, Fukuoka (BNT162b2, Placebo)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Placebo
  • Sumida-ku, Tokyo, Japan
  • +1 more
Jan 13, 2023

Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))

Active, not recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Birmingham, Alabama
  • +52 more
Mar 16, 2022

Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)

Recruiting
  • Diabetic Retinopathy
  • Runcaciguat (BAY1101042)
  • Placebo
  • Redlands, California
  • +85 more
Jan 30, 2023

Type 2 Diabetes Treated With Insulin, Pregnancy, High Risk Trial in Worcester (Continuous Glucose Monitor, Routine Capillary

Not yet recruiting
  • Type 2 Diabetes Treated With Insulin
  • Pregnancy, High Risk
  • Continuous Glucose Monitor
  • Routine Capillary Blood Glucose Monitoring (Fingerstick Glucose)
  • Worcester, Massachusetts
    University of Massachusetts Memorial Medical Center
Apr 6, 2022

Tardive Dyskinesia Trial in Worldwide (SD-809, Placebo)

Completed
Has Results
  • Tardive Dyskinesia
  • Tuscaloosa, Alabama
  • +105 more
Nov 5, 2021